作为重度预先治疗的转移性肉 Sarcoma 患者的救援疗法的单剂temozolomide
Izzet Dogan1, Nail Paksoy, Mert Basaran
1Medical Oncology, Istanbul University Institute of Oncology, Istanbul, Turkey.
Journal of cancer research and therapeutics
|March 30, 2024
概括
泰莫佐洛米德的疗效有限,但在预先治疗的转移性软组织肉瘤患者中耐受性良好. 它可以被认为是一个单剂的选择,广泛治疗的个人.
科学领域:
- 医学瘤学 医学瘤学
- 肉瘤研究研究 肉瘤研究
- 临床试验 临床试验
背景情况:
- 转移性肉瘤的治疗选择有限.
- 研究新的治疗策略对于改善患者的治疗结果至关重要.
研究的目的:
- 评估temozolomide在经过预先治疗的转移软组织肉瘤患者的疗效和安全性.
主要方法:
- 病理学,临床和治疗数据的回顾性分析.
- 在16名患者中评估temozolomide的疗效和副作用.
主要成果:
- 无进展生存时间的中位数为3.5个月.
- 观察到一个部分反应 (6.3%) 和四个稳定疾病病例 (25%).
- 泰莫佐洛米德的耐受性一般很好,大多数是1-2级的不良事件.
结论:
- 泰莫佐洛米德在预先治疗的转移性肉瘤中表现出有限的疗效但良好的耐受性.
- 它可以被视为单剂治疗选择,用于重度预治疗的患者.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523


